Stephens raised the firm’s price target on Ensign Group (ENSG) to $170 from $165 and keeps an Overweight rating on the shares. Despite Ensign contending with uncertainty surrounding the long-term Medicaid reimbursement backdrop for Skilled Nursing Facilities, fundamentals “have not wavered,” says the analyst, who raises estimates following the company’s Q2 report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENSG: